Skip Page Header

Home > MDMA (‘ecstasy’): a review of its harms and classification under the Misuse of Drugs Act 1971.

Advisory Council on the Misuse of Drugs. (2009) MDMA (‘ecstasy’): a review of its harms and classification under the Misuse of Drugs Act 1971. London: Home Office.

[img]
Preview
PDF (Ecstasy report) - Published Version
330kB

3,4-Methylenedioxymethylamphetamine (MDMA), colloquially known as ‘ecstasy’, is a Class A drug in the UK, the use of which increases the feeling of euphoria and induces a heightened sense of intimacy with others.

This report is based on a review of the literature, including journal articles, books and other literature. The ACMD also considered oral and written evidence (Annexes C and D respectively) submitted by organisations and individuals with particular expertise and special interest in MDMA.


Item Type
Report
Publication Type
International, Report, Review
Drug Type
CNS stimulants
Intervention Type
Harm reduction
Date
2009
Pages
49 p.
Publisher
Home Office
Corporate Creators
Advisory Council on the Misuse of Drugs
Place of Publication
London
EndNote
Accession Number
HRB (Electronic Only)
Related URLs

Repository Staff Only: item control page